Announce Date | 02/27/2025 |
EPS Normalized Actual | $0.14 (Miss by $-0.2) |
EPS GAAP Actual | $0.14 (Miss by $-0.2) |
Revenue Actual | $0.68731B |
Revenue Surprise | Beat by $687.31M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.72 | 7.93 | 4.65247 | 4.83931 | 1 |
Dec 2028 | 5.8 | 6.46 | 5.67783 | 5.9291 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -2.63 | -2.63 | 0.68731B | 46% | 687.31M |
FQ3 2024 (Sep 2024) | 1.11 | 1.11 | 0.19492B | -331.98% | 194.92M |
FQ2 2024 (Jun 2024) | 1.09 | 1.09 | 0.571616B | 12.36% | 571.62M |
FQ1 2024 (Mar 2024) | 0 | 0 | 0.017316B | 25.15% | 17.32M |
FQ4 2023 (Dec 2023) | -0.18 | -0.18 | 0.371123B | 100% | 371.12M |
FQ3 2023 (Sep 2023) | 4.22 | 4.22 | 0.842009B | 100% | 842.01M |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 0.500982B | 100% | 500.98M |
FQ1 2023 (Mar 2023) | 0 | 0 | 0.012961B | 100% | 12.96M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.63 | -- | 0.61364 | 0.64893 | 1 |
FQ3 2027 (Sep 2027) | 3.62 | -- | 3.52602 | 3.72879 | 1 |
FQ2 2027 (Jun 2027) | 1.53 | -- | 1.49028 | 1.57598 | 1 |
FQ1 2027 (Mar 2027) | -2.39 | -- | -2.46182 | -2.32795 | 1 |
FQ4 2026 (Oct 2026) | 4.93293 | -- | 4.73675 | 5.07775 | 3 |
FQ3 2026 (Jul 2026) | 1.43592 | -- | 1.37881 | 1.47808 | 4 |
FQ2 2026 (Jun 2026) | 2.08676 | -- | 2.08676 | 2.08676 | 3 |
FQ1 2026 (Mar 2026) | -2.31452 | -- | -2.51466 | -2.15753 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.78B | -- | 0.76B | 0.8B | 3 |
FQ3 2027 (Sep 2027) | 1.56B | -- | 1.53B | 1.6B | 3 |
FQ2 2027 (Jun 2027) | 1.13B | -- | 1.11B | 1.15B | 3 |
FQ1 2027 (Mar 2027) | 0.28B | -- | 0.27B | 0.28B | 3 |
FQ4 2026 (Oct 2026) | 0.92B | -- | 0.89B | 0.94B | 4 |
FQ3 2026 (Jul 2026) | 0.56B | -- | 0.54B | 0.57B | 5 |
FQ2 2026 (Jun 2026) | 1.09B | -- | 1.09B | 1.09B | 8 |
FQ1 2026 (Mar 2026) | 0.1B | -- | 0.1B | 0.11B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -2.63 | -2.63 | 100% | |
FQ3 2024 (Sep 2024) | 1.11 | 1.11 | 100% | |
FQ2 2024 (Jun 2024) | 1.09 | 1.09 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | -0.18 | -0.18 | 100% | |
FQ3 2023 (Sep 2023) | 4.22 | 4.22 | 100% | |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 100% | |
FQ1 2023 (Mar 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.69B | $687.31M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.19B | $194.92M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.57B | $571.62M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.02B | $17.32M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.37B | $371.12M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.84B | $842.01M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.5B | $500.98M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.01B | $12.96M | 100% |